Mckesson Corp. (MCK)
NYSE:MCK

McKesson (MCK) Stock Price & Analysis

1,633 Followers

MCK Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$395.30 - $612.17
Previous Close$595.73
Volume634.06K
Average Volume (3M)720.73K
Market Cap
$77.27B
Enterprise Value$80.45B
Total Cash (Recent Filing)$4.58B
Total Debt (Recent Filing)$7.39B
Price to Earnings (P/E)26.6
Beta0.22
Aug 07, 2024
Dividend Yield0.42%
Share Statistics
EPS (TTM)22.37
Shares Outstanding129,985,514
10 Day Avg. Volume605,968
30 Day Avg. Volume720,726
Standard Deviation0.06
R-Squared0.17
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)-5.55
Price to Sales (P/S)0.28
Price to Cash Flow (P/CF)77.20
P/FCF Ratio121.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.26
Enterprise Value/Gross Profit6.51
Enterprise Value/Ebitda17.21
Forecast
Price Target Upside4.78% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering15

Bulls Say, Bears Say

Bulls Say
Financial PerformanceStable utilization drives core performance in US Pharma.
Growth DriversStrong broader healthcare utilization trends are translating to sustained positive fundamental momentum in the company's core.
Strategic WinsThe company's ability to recapture this contract should be viewed favorably.
Bears Say
EarningsFQ4:24 adjusted EPS of $6.18 missed our and consensus estimates by -3.6% and -2.0%, respectively.
Financial PerformanceMcKesson reported a weaker than expected quarter with revenue, operating profit and EPS all missing Street expectations.
RevenuePrescription Technology Solutions revenue of $1.2B was 8.0% below the analyst's estimate.
---

Financials

Annual

Ownership Overview

0.57%23.84%23.46%52.14%
23.46% Other Institutional Investors
52.14% Public Companies and Individual Investors

Risk Analysis

Main Risk Category
ProductionRisks related to the company’s ability to manufacture goods and services

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

MCK FAQ

What was Mckesson Corp.’s price range in the past 12 months?
Mckesson Corp. lowest stock price was $395.30 and its highest was $612.17 in the past 12 months.
    What is Mckesson Corp.’s market cap?
    Currently, no data Available
    When is Mckesson Corp.’s upcoming earnings report date?
    Mckesson Corp.’s upcoming earnings report date is Aug 07, 2024 which is in 11 days.
      How were Mckesson Corp.’s earnings last quarter?
      Mckesson Corp. released its earnings results on May 07, 2024. The company reported $6.18 earnings per share for the quarter, missing the consensus estimate of $6.358 by -$0.178.
        Is Mckesson Corp. overvalued?
        According to Wall Street analysts Mckesson Corp.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Mckesson Corp. pay dividends?
          Mckesson Corp. pays a Quarterly dividend of $0.62 which represents an annual dividend yield of 0.42%. See more information on Mckesson Corp. dividends here
            What is Mckesson Corp.’s EPS estimate?
            Mckesson Corp.’s EPS estimate is $7.21.
              How many shares outstanding does Mckesson Corp. have?
              Mckesson Corp. has 129,710,820 shares outstanding.
                What happened to Mckesson Corp.’s price movement after its last earnings report?
                Mckesson Corp. reported an EPS of $6.18 in its last earnings report, missing expectations of $6.358. Following the earnings report the stock price went down -0.393%.
                  Which hedge fund is a major shareholder of Mckesson Corp.?
                  Among the largest hedge funds holding Mckesson Corp.’s share is Viking Global Investors LP. It holds Mckesson Corp.’s shares valued at 317M.
                    ---

                    Company Description

                    Mckesson Corp.

                    Incorporated in 1833, Texas-based McKesson Corp. provides pharmaceuticals, health information technology, medical supplies, and care management tools. The company operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions, International, and Medical-Surgical Solutions.
                    ---

                    MCK Company Deck

                    ---

                    MCK Earnings Call

                    Q4 2024
                    0:00 / 0:00
                    ---

                    MCK Revenue Breakdown

                    86.96%86.96%7.44%4.02%1.59%
                    86.96% U.S. Pharmaceutical
                    7.44% International
                    4.02% Medical-Surgical Solutions
                    1.59% Prescription Technology Solutions
                    tipranks
                    ---

                    MCK Stock 12 Month Forecast

                    Average Price Target

                    $628.87
                    ▲(4.78% Upside)
                    {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"409":"$409","552":"$552","695":"$695","480.5":"$480.5","623.5":"$623.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":694,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$694.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":628.87,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$628.87</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":540,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$540.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[409,480.5,552,623.5,695],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2023","6":"Jan<br/>2024","9":"Apr<br/>2024","12":"Jul<br/>2024","25":"Jul<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,587.76,595.9323076923076,604.1046153846154,612.276923076923,620.4492307692308,628.6215384615384,636.7938461538462,644.9661538461538,653.1384615384616,661.3107692307692,669.483076923077,677.6553846153846,685.8276923076924,{"y":694,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,587.76,590.9223076923076,594.0846153846154,597.246923076923,600.4092307692308,603.5715384615385,606.7338461538461,609.8961538461539,613.0584615384615,616.2207692307692,619.3830769230769,622.5453846153846,625.7076923076924,{"y":628.87,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,587.76,584.0861538461538,580.4123076923076,576.7384615384615,573.0646153846154,569.3907692307693,565.7169230769231,562.0430769230769,558.3692307692307,554.6953846153846,551.0215384615385,547.3476923076923,543.6738461538462,{"y":540,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":412.14,"date":1689897600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":419.62,"date":1691107200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":410.84,"date":1693526400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":443.68,"date":1696550400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":451.12,"date":1698969600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":463.59,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":477.1,"date":1704412800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":503.3,"date":1706832000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":525.31,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":538.16,"date":1712275200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":528.28,"date":1714694400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":586.9,"date":1717718400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":587.76,"date":1720137600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Cardinal Health
                    CVS Health
                    Walgreens Boots Alliance
                    Medtronic

                    Best Analysts Covering MCK

                    1 Year
                    Michael ChernyLeerink Partners
                    1 Year Success Rate
                    17/18 ratings generated profit
                    94%
                    1 Year Average Return
                    +33.53%
                    assigned a buy rating 3 months ago
                    Copying Michael Cherny's trades and holding each position for 1 Year would result in 94.44% of your transactions generating a profit, with an average return of +33.53% per trade.
                    Popular Stocks
                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis